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To the editor 
We commend Twose et al for their qualitative study conducted with sixteen patients 
who had therapeutic thoracocentesis for malignant pleural effusions (MPE)1. 
Respiratory symptoms improved while constitutional symptoms did not; and even 
though symptomatic benefit was only for a matter of days, patients thought that it 
was worth any discomfort. 
We conducted a similar study with 10 patients with MPE who were identified by the 
pleural team at a large district general hospital. Patients were interviewed four weeks 
after a talc pleurodesis or placement of an in-dwelling pleural catheter (IPC). An IPC 
is a plastic tube which can be placed during a day case procedure and allows 
intermittent fluid drainage in the community. 
A semi-structured electronically recorded interview was conducted by a researcher 





We had a male and mesothelioma preponderance with 8 of 10  male and 6  had 
mesothelioma. Thoracocentesis was the initial pleural instrumentation for all (some 
therapeutic, some diagnostic) but subsequently 9 of 10 had an IPC and 6 of 10 had 
attempted talc pleurodesis (some had both). Pre-procedure symptoms were 
respiratory and constitutional. For some thoracocentesis was uncomfortable. Where 
our study differs from Twose et al is the additional data with regard to patients 
undergoing IPC and pleurodesis. 
 
In general IPC placement was well tolerated and patients liked that  as a result of the 
IPC there was no need to return to hospital for further thoracocentesis. Care at 
home, with the support of District Nurses was greatly appreciated, despiteoccasional 
frustrations. For some, placement of an IPC led to a gradual reduction of fluid 
drainage and pleurodesis with tube removal.  For some, subsequent tube removal 
did not change quality of life, for others it felt liberating.  
For those undergoing chest drain and pleurodesis, there was some dissatisfaction 
that this necessitated a hospital stay and the chest drain bottle was inconvenient, but 
improvements in quality of life were worth the effort. We asked patients to reflect on 
the journey they had taken and whether they would have chosen the same pleural 
interventions again (multiple therapeutic thoracocenteses versus pleurodesis or 
IPC). Patients fell into two categories: those who thought that the decision should be 
made by the medical team and those who were keen for a particular option such as 





While our findings with regards to removal of pleural fluid are similar to Twose et al’s, 
our data give some interesting insights into the experiences of patients who have 
undergone IPC or pleurodesis. Both procedures have burdens and benefits and it is 
important that patients are guided by clinicians so that they can make informed 
choices.. 
Table 1: Perceptions of patients after IPC placement or talc pleurodesis 
 
Perception of patient Exemplar quote(s) 
IPC 
Placement was generally well tolerated  “It wasn’t very pleasant, but it was pain-
free, it was just a lot of, sort of, faffing 
position-wise, and pushing, and shoving, 
and prodding…” (Patient 7) 
No need to return to hospital “I wouldn’t want to stay in hospital unless I 
really had to.” (Patient 1) 
Community support “…there was a hiccup the first weekend, 
the district nurses didn’t turn up.” (Patient 
6) 
IPC leading to pleurodesis Initially, it was every couple of days, but 
now, for the last few weeks, or even four 






 “Oh very definitely,(worth not 
having to come to hospital) (Patient 4) 
“I don’t recall any particular pain from it, it 
was just the fact you wanted to go to the 
loo you’ve got to somehow drag this bucket 
around with you.” (Patient 4) 
Decision making  
Medical team lead on decision making “Medical people, they should know which 
you need most.” (Patient 2) 
Patient taking lead on decision making “…you may have to have regular visits all 
the time, and that means, constant 
interference.  I mean, it’s not the most 
pleasant experience, and there’s a degree 
of pain in it…You need something a bit 
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